ORBIMED ADVISORS LLC – X4 Pharmaceuticals, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$8.59M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+77.20%
quarter
X4 Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +265.89% | 3.65M shares | 7.27M | $1.71 | 5.02M |
Q2 2022 | share | 0.00% | 0 shares | -1.07M | $0.97 | 1.37M | |
Q1 2022 | share | 0.00% | 0 shares | -742K | $1.75 | 1.37M | |
Q4 2021 | share | 0.00% | 0 shares | -4.12M | $2.27 | 1.37M | |
Q3 2021 | share | 0.00% | 0 shares | -1.66M | $5.29 | 1.37M | |
Q2 2021 | share | 0.00% | 0 shares | -2.89M | $6.5 | 1.37M | |
Q1 2021 | share | Increase | +26.45% | 287.35K shares | 4.84M | $8.61 | 1.37M |
Q4 2020 | share | 0.00% | 0 shares | -370K | $6.43 | 1.08M | |
Q3 2020 | share | 0.00% | 0 shares | -2.77M | $6.77 | 1.08M | |
Q2 2020 | share | 0.00% | 0 shares | -739K | $9.32 | 1.08M | |
Q1 2020 | share | 0.00% | 0 shares | -760K | $10 | 1.08M | |
Q4 2019 | share | Increase | +16.02% | 150K shares | -278K | $10.7 | 1.08M |
Q3 2019 | share | 0.00% | 0 shares | -2.14M | $12.71 | 936.49K | |
Q2 2019 | share | Increase | +200.65% | 625K shares | 8.62M | $15 | 936.49K |
Q1 2019 | share | Increase | 0.00% | 311.49K shares | 5.42M | $17.41 | 311.49K |